Methylene blue is neuroprotective against mild traumatic brain injury

Journal of Neurotrauma

Volumn 31, Issue 11, 2014, Pages 1063-1071

  Talley Watts, Lora ^a,b   Long, Justin Alexander ^a   Chemello, Jonathan ^a   Van Koughnet, Samantha ^a   Fernandez, Angelica ^a   Huang, Shiliang ^a   Shen, Qiang ^a   Duong, Timothy Q ^a,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

antioxidant; mitochondria; MRI; oxidative stress; vasogenic edema

Indexed keywords

METHYLENE BLUE; ANTIOXIDANT; FLUORESCENT DYE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN SIZE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FOOT; FORELIMB; FUNCTIONAL ASSESSMENT; IMMUNOHISTOLOGY; MALE; NERVE CELL DEGENERATION; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPROTECTION; NISSL STAINING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY SOMATOSENSORY CORTEX; RAT; RAT MODEL; SCORING SYSTEM; SENSORIMOTOR FUNCTION; TRAUMATIC BRAIN INJURY; ANIMAL; ANIMAL BEHAVIOR; BRAIN; BRAIN INJURIES; PATHOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BRAIN; BRAIN INJURIES; FLUORESCENT DYES; MAGNETIC RESONANCE IMAGING; MALE; METHYLENE BLUE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84901981561     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3193     Document Type: Article

References (46)

1. Nortje, J., and Menon, D.K. (2004). Traumatic brain injury: physiology, mechanisms, and outcome. Curr. Opin. Neurol. 17, 711-718.
2. Chaturvedi, R.K., and Beal, M.F. (2008). Mitochondrial approaches for neuroprotection. Ann. N. Y. Acad. Sci 1147, 395-412.
3. Galluzzi, L., Morselli, E., Kepp, O., and Kroemer, G. (2009). Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochim. Biophys. Acta 1787, 402-413.
4. Scheindlin, S. (2008). Something old. something blue. Mol. Interv. 8, 268-273.
5. Bruchey, A.K., and Gonzalez-Lima, F. (2008). Behavioral, physiological and biochemical hormetic responses to the autoxidizable dye methylene blue. Am. J. Pharmacol. Toxicol. 3, 72-79.
6. Clifton, J., 2nd, and Leikin, J.B. (2003). Methylene blue. Am. J. Ther. 10, 289-291.
7. Scott, A., and Hunter, F.E., Jr. (1966). Support of thyroxine-induced swelling of liver mitochondria by generation of high energy intermediates at any one of three sites in electron transport. J. Biol. Chem. 241, 1060-1066.
8. Zhang, X., Rojas, J.C., and Gonzalez-Lima, F. (2006). Methylene blue prevents neurodegeneration caused by rotenone in the retina. Neuro-tox. Res. 9, 47-57.
9. Lindahl, P.E., and Oberg, K.E. (1961). The effect of rotenone on respiration and its point of attack. Exp. Cell. Res. 23, 228-237.
10. Riha, P.D., Bruchey, A.K., Echevarria, D.J., and Gonzalez-Lima, F. (2005). Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. Eur. J. Pharmacol. 511, 151-158.
11. Rojas, J.C., Bruchey, A.K., and Gonzalez-Lima, F. (2012). Neuro-metabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog. Neurobiol. 96, 32-45.
12. Lin, A.L., Poteet, E., Du, F., Gourav, R.C., Liu, R., Wen, Y., Bresnen, A., Huang, S., Fox, P.T., Yang, S.H., and Duong, T.Q. (2012). Me-thylene blue as a cerebral metabolic and hemodynamic enhancer. PLoS One 7, e46585.
13. Huang, S., Du, F., Shih, Y.Y., Shen, Q., Gonzalez-Lima, F., and Duong, T.Q. (2013). Methylene blue potentiates stimulus-evoked fMRI responses and cerebral oxygen consumption during normoxia and hypoxia. Neuroimage 72C, 237-242.
14. Rojas, J.C., Bruchey, A.K., and Gonzalez-Lima, F. (2012). Meur-ometabolic mechanisms for memory enhancement and neuroprotec-tion of methylene blue. Prog. Neurobiol. 96, 32-45.
15. Yoo, A.J., Sheth, K.N., Kimberly, W.T., Chaudhry, Z.A., Elm, J.J., Jacobson, S., Davis, S.M., Dommam, G.A., Albers, G.W., Stern, B.J., and Gonzalez, R.G. (2012). Validating imaging biomarkers of cerebral edema in patients with severe ischemic stroke. J. Stroke Cerebrovasc. Dis. 22, 742-749.
16. Medina, D.X., Caccamo, A., and Oddo, S. (2011) Methylene Blue reduces aB levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol. 21, 140-149.
17. Wen, Y., Li, W., Poteet, E.C., Xie, L., Tan, C., Yan, L.J., Ju, X., Liu, R., Qian, H., Marvin, M.A., Goldberg, M.S., She, H., Mao, Z., Simpkins, J.W., and Yang, S.-H. (2011) Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J. Biol. Chem. 286, 16504-16515.
18. Shen, Q., Du, F., Huang, S., Rodriguez, P., Watts, L.T., and Duong, T.Q. (2013, in revison). Neuroprotective efficacy of methylene blue in ischemic stroke: an MRI study. PLoS One 8, e79833.
19. Oz, M., Lorke, D.E., and Petroianu, G.A.(2009). Methylene blue and Alzheimer's disease. Biochem. Pharmacol. 78, 927-932.
20. rd, Jones, J. R., Kraft, C., Peters, M., Abisambra, J. F., Duff, K. E., Weeber, E. J., Gestwicki, J. E., and Dickey, C. A. (2010). Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Mol. Neurodegener. 5, 45.
21. Shen, Q., Meng, X., Fisher, M., Sotak, C.H., and Duong, T.Q. (2003). Pixel-by-pixel spatiotemporal progression of focal ischemia derived using quantitative perfusion and diffusion imaging. J. Cereb. Blood Flow Metab. 23, 1479-1488.
22. Shen, Q., Ren, H., Cheng, H., Fisher, M., and Duong, T.Q. (2005). Functional, perfusion and diffusion MRI of acute focal ischemic brain injury. J. Cereb. Blood Flow Metab. 25, 1265-1279.
23. Meng, X., Fisher, M., Shen, Q., Sotak, C.H., and Duong, T.Q. (2004). Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann. Neurol. 55, 207-212.
24. Hernandez, T.D., and Schallert, T. (1988). Seizures and recovery from experimental brain damage. Exp. Neurol. 102, 318-324.
25. Deitch, A.D., and Moses, M.J. (1957). The Nissl substance of living and fixed spinal ganglion cells. II. An ultraviolet absorption study. J. Biophys. Biochem. Cytol. 3, 449-456.
26. Watts, L., Sprague, S., Zheng, W., Galrling, R., Jiminez, D., Digi-caylioglu, M., and Lechleiter, J.D. (2013). Purinergic 2Y1 receptor stimulation decreases cerebral edema and reactive gliosis in a traumatic brain injury model. J. Neurotrauma 30, 55-66.
27. Schmued, L.C., and Hopkins, K.J. (2000). Fluoro-Jade: novel fluoro-chromes for detecting toxicant-induced neuronal degeneration. Tox-icol. Pathol. 28, 91-99.
28. Schmued, L.C., and Hopkins, K.J. (2000). Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874, 123-130.
29. O'Leary, J.L., Petty, J., Harris, A.B., and Inukai, J. (1968). Su-pravital staining of mammalian brain with intra-arterial methylene blue followed by pressurized oxygen. Stain Technol. 43, 197-201.
30. Azbill, R.D., Mu, X., Bruce-Keller, A.J., Mattson, M.P., and Springer, J.E. (1997). Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res. 765, 283-290.
31. Palzur, E., Zaaroor, M., Vlodavsky, E., Milman, F., and Soustiel, J.F. (2008). Neuroprotective effect of hyperbaric oxygen therapy in brain injury is mediated by preservation of mitochondrial membrane properties. Brain Res. 1221, 126-133.
32. Okonkwo, D.O., and Povlishock, J.T. (1999). An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J. Cereb. Blood Flow Metab. 19, 443-451.
33. Sullivan, P.G., Rabchevsky, A.G., Hicks, R.R., Gibson, T.R., Fletcher-Turner, A., and Scheff, S.W. (2000). Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 101, 289-295.
34. Sullivan, P.G., Thompson, M., and Scheff, S.W. (2000). Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury. Exp. Neurol. 161, 631-637.
35. Empey, P.E., McNamara, P.J., Young, B., Rosbolt, M.B., and Hatton, J. (2006). Cyclosporin A disposition following acute traumatic brain injury. J. Neurotrauma 23, 109-116.
36. Mazzeo, A.T., Kunene, N.K., Gilman, C.B., Hamm, R.J., Hafez, N., and Bullock, M.R. (2006). Severe human traumatic brain injury, but not cyclosporin a treatment, depresses activated T lymphocytes early after injury. J. Neurotrauma 23, 962-975.
37. Merenda, A., and Bullock, R. (2006). Clinical treatments for mito-chondrial dysfunctions after brain injury. Curr. Opin. Crit. Care 12, 90-96.
38. Salaris, S.C., Babbs, C.F., and Voorhees, W.D., 3rd (1991). Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. Biochem. Pharmacol. 42, 499-506.
39. Poteet, E., Winters, A., Yan, L.J., Shufelt, K., Green, K.N., Simpkins, J.W., Wen, Y., and Yang, H. (2012). Neuroprotective actions of methylene blue and its derivatives. PLoS One 7, e48279.
40. Miclescu, A., Sharma, H.S., Martijn, C., and Wiklund, L. (2010). Me-thylene blue protects the cortical blood-brain barrier against ischemia/reperfusion-induced disruptions. Crit. Care Med. 38, 2199-2206.
41. Bardakci, H., Kaplan, S., Karadeniz, U., Ozer C, Bardakci Y, Ozogul, C., Birincioglu, C.L., and Cobanoglu, A. (2006). Methylene blue decreases ischemia-reperfusion (I/R)-induced spinal cord injury: an in vivo study in an I/R rabbit model. Eur. Surg. Res. 38, 482-488.
42. McIntosh, T.K. (1993). Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review. J. Neurotrauma 10, 215-261.
43. Hensley, K., Carney, J.M., Stewart, C.A., Tabatabaie, T., Pye, Q., and Floyd, R.A. (1997). Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies. Int. Rev. Neuro-biol. 40, 299-317.
44. Vink, R., Faden, A.I., and McIntosh, T.K. (1988). Changes in cellular bioenergetic state following graded traumatic brain injury in rats: determination by phosphorus 31 magnetic resonance spectroscopy. J. Neurotrauma 5, 315-330.
45. Clifton, G.L., Lyeth, B.G., Jenkins, L.W., Taft, W.C., DeLorenzo, R.J., and Hayes, R.L. (1989). Effect of D, alpha-tocopheryl succinate and polyethylene glycol on performance tests after fluid percussion brain injury. J. Neurotrauma 6, 71-81.
46. Halks-Miller, M., Henderson, M., and Eng, L.F. (1986). Alpha to-copherol decreases lipid peroxidation, neuronal necrosis, and reactive gliosis in reaggregate cultures of fetal rat brain. J. Neuropathol. Exp. Neurol. 45, 471-484.